Welcome to LookChem.com Sign In|Join Free

CAS

  • or
BENZENEMETHANAMINE, 4-BROMO-ALPHA-PHENYL-, (R)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

220441-81-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 220441-81-6 Structure
  • Basic information

    1. Product Name: BENZENEMETHANAMINE, 4-BROMO-ALPHA-PHENYL-, (R)-
    2. Synonyms: BENZENEMETHANAMINE, 4-BROMO-ALPHA-PHENYL-, (R)-
    3. CAS NO:220441-81-6
    4. Molecular Formula:
    5. Molecular Weight: 262.14508
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 220441-81-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: BENZENEMETHANAMINE, 4-BROMO-ALPHA-PHENYL-, (R)-(CAS DataBase Reference)
    10. NIST Chemistry Reference: BENZENEMETHANAMINE, 4-BROMO-ALPHA-PHENYL-, (R)-(220441-81-6)
    11. EPA Substance Registry System: BENZENEMETHANAMINE, 4-BROMO-ALPHA-PHENYL-, (R)-(220441-81-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 220441-81-6(Hazardous Substances Data)

220441-81-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 220441-81-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,4,4 and 1 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 220441-81:
(8*2)+(7*2)+(6*0)+(5*4)+(4*4)+(3*1)+(2*8)+(1*1)=86
86 % 10 = 6
So 220441-81-6 is a valid CAS Registry Number.

220441-81-6Relevant articles and documents

Compounds for Treating Cannabinoid Toxicity and Acute Cannabinoid Overdose

-

Paragraph 0500, (2022/02/11)

The present invention relates to novel compounds that can act as antidotes for treating “Acute Cannabinoid Overdose” produced by classical cannabinoids such as Δ9-tetrahydrocannabinol (THC) and several synthetic psychoactive cannabinoids (SPCs). The cannabis constituent THC exerts its psychotropic effects via CB1 receptor activation and SPCs mimic the effects of THC with higher potency and severe neurotoxicity. Compounds disclosed in this invention, their enantiomers, diastereomers, geometric isomers, racemates, tautomers, rotamers, atropisomers, metabolites, N-oxides, salts, solvates, hydrates, isotopic variations and their polymorphic forms can be therapeutically useful in an emergency setting for counteracting the intoxicating effects of acute THC ingestion and SPC overdose. Also, aspects of the invention are concerned with pyrazoles, imidazoles, triazoles, thiazoles, oxazoles, dihydropyrazoles, pyrrolidinones, azetidines, oxyazetidines and azaspiro[3.3]heptanes with unique pharmacokinetic and pharmacodynamic properties for treating “Acute Cannabinoid Overdose”.

MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF

-

Paragraph 0317, (2021/01/23)

The disclosure relates to compounds and pharmaceutical compositions capable of modulating the hydroxysteroid 17-beta dehydrogenase (HSD17B) family member proteins including inhibiting the HSD17B member proteins, e.g. HSD17B13. The disclosure further relates to methods of treating liver diseases, disorders, or conditions with the compounds and pharmaceutical compositions disclosed herein, in which the HSD17B family member protein plays a role.

Hydrogen bond directed aerobic oxidation of amines via photoredox catalysis

Wang, Hongyu,Man, Yunquan,Wang, Kaiye,Wan, Xiuyan,Tong, Lili,Li, Na,Tang, Bo

, p. 10989 - 10992 (2018/10/08)

An application of H-bonding interactions for directing the α-C-H oxidation of amines to amides and amino-ketones catalyzed by an organic photocatalyst is reported. The high efficiency of this method is demonstrated by the aerobic oxidation of pyrrolidines, diarylamines and benzylamines bearing urea groups with high yields and a wide substrate scope.

SUBSTITUTED PYRIMIDINES

-

Page/Page column 37; 38, (2013/04/10)

The present invention relates to substituted pyrimidines useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.

SUBSTITUTED PYRIMIDINES

-

, (2013/04/10)

Disclosed are substituted pyrimidines useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.

Bis-sulfamyl imines: Potent substrates for asymmetric additions of arylboroxines under rhodium catalysis

Crampton, Rosemary,Woodward, Simon,Fox, Martin

supporting information; experimental part, p. 903 - 906 (2011/06/19)

Bis-sulfamyl imines are shown to be potentially ideal substrates for rhodium-catalysed asymmetric additions of arylboron nucleophiles as they show: (i) near perfect enantioselectivities (11 examples, 98-99+% ee), (ii) good to excellent diastereoselectivities (10-32:1 rac:meso), and (iii) high functional group tolerance in removal of the low molecular weight protecting group via mild heating in aqueous pyridine.

METHODS OF PREPARING PRIMARY, SECONDARY AND TERTIARY CARBINAMINE COMPOUNDS IN THE PRESENCE OF AMMONIA

-

Page/Page column 52; 64, (2008/12/04)

The present application relates to novel methods for the preparation of primary, secondary and tertiary carbinamine compounds, particularly the preparation of compounds of formulae I, IV and VI, from a carbonyl compound of formula II in the presence of ammonia or an ammonium equivalent of the formula NH4+X-, by way of allylation, crotylation, arylation, reductive amination and catalytic hydrogenation.

METHODS OF PREPARING SECONDARY CARBINAMINE COMPOUNDS WITH BORONIC ACIDS

-

Page/Page column 28; 36, (2008/12/04)

The present application relates to novel methods for the preparation of secondary carbinamine compounds, particularly the preparation of secondary carbinamine compounds of the formula Ia, formula Ib or formula IV from aldehydes of the formula II and boronic acids of the formula III or formula V, in the presence of ammonia or an ammonia equivalent of the formula NH4+X-.

C2-symmetric bicyclo[3.3.1]nonadiene as a chiral ligand for rhodium-catalyzed asymmetric arylation of N-(4-nitrobenzenesulfonyl)arylimines

Otomaru, Yusuke,Tokunaga, Norihito,Shintani, Ryo,Hayashi, Tamio

, p. 307 - 310 (2007/10/03)

(Chemical Equation Presented) Asymmetric synthesis of diarylmethylamines with high enantioselectivity (95-99percent ee) was realized by use of a new C 2-symmetric diene ligand, (1R,5R)-2,6-diphenylbicyclo[3.3.1]nona-2,6- diene (Ph-bnd*), for th

Pyrazolopyrimidines as therapeutic agents

-

, (2008/06/13)

The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 220441-81-6